ADM Antibodies

Santa Cruz Biotechnology features a diverse variety of ADM Antibodies for advanced research in molecular biology. Monoclonal ADM Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Adrenomedullin (ADM) is a potent vasodilator and plays a crucial role in cardiovascular homeostasis, regulating blood pressure and fluid balance. ADM is involved in various physiological processes, including angiogenesis and inflammation, making it a significant target for research in cardiovascular diseases and other related conditions. Understanding ADM function is essential for developing therapeutic strategies aimed at managing cardiovascular diseases. ADM research continues to reveal new insights into cellular signaling pathways and potential therapeutic applications. Ongoing studies of ADM mechanisms contribute to our understanding of cardiovascular regulation and disease progression. ADM investigation helps identify novel therapeutic targets for treating various cardiovascular conditions. Santa Cruz Biotechnology monoclonal ADM antibodies support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic strategies for cardiovascular diseases.